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Translocate across plasma membranes in a 
nonreceptor-mediated fashion(b1)
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Cargo: Drug,protein,SiRNA,PNA,plasmid,etc
CPP (5-30 aa)
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CPP:Intracellular delivery vehicle
 In 1988
HIV-coded Tat regulatory protein
Taken up by cells in culture media
 In 1991
pAntp(43–58) (later called penetratin) 
The homeodomain of Antennapedia 
(Drosophila homeoprotein)
Internalize via receptor-independent manner
Studied by site-directed mutagenesis;
43 to 58 amino acids necessary for translocation 
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Short cationic 
sequences
 Also called:
PTDs(Protein Transduction Domains)
AID(arginine-rich intracellular delivery)
 Be useful for the treatment of
inflammatory bowel disease, diabetes and muscular 
dystrophy
6
CPPs
Cytosol/Nucleus
Imagin
g 
agents
Reporter 
molecule
s
Therapeuti
cs
7
Membran translocation(4)
Be biodegradable and biocompatible
Lack intrinsic toxicity and antigenicity,
 Show no accumulation in the body,
Maintain the delivered drug activity until it reaches the site 
of action(6)
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Drug carrier properteis
Have remarkably low toxicity
Have an extensive range of possible cargo types
Unlike viral vectors, do not integrate the genetic
material they deliver
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Successful delivery to numerous cell types
(unlike liposomes)
Resist degredation (after internalization)
adding homing sequences to the CPP(5)
10
Protein derived chimeric Designed/synthetic
Penetratin(pAnt)
(Drosophila 
Antennapedia)
MPG(HIV fused with T-
Ag of SV40 virus)
MAP(amphipathic model 
peptide)
Tat (48-60)
(HIV-1)
Pep-1(SV40) CADY(derived from 
PPTG1 peptide)
pVEC(VE-cadherin) Transportan/TP10
(Galanin and 
mastoparan)
POD(peptide for 
ocular delivery)
VP22 peptide
(Herpes simplex virus)
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Classification(5)
Tat uptake is :
Time-independent 
Concentration dependant
Partially inhibited by loweing temprature
Tat   deliver beta-galactosidase (b-Gal) to all tissues 
 Peptides fused to TAT enter cells within seconds*
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TAT
 In the construction of nanocarriers
delivery the drugs to tumors
Enable delivery of molecules useful in treatment of
allergies and production of vaccines
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TAT
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Each CPP expresses its own preferred mechanism of uptake(1)
Mechanisms of uptake across the plasma membrane(3)
Energy-dependent endocytosis
Macropynocytosis
Clatrin-mediated endocytosis
Caveolin/lipid raft mediated endocytosis
Energy-independent direct translocation
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 Various properties of peptides, such as: 
molecule length 
charge delocalization
 the properties of the associated cargo, such as :
size 
Charge
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Factors that affect the uptake
mechanism(4)
Fields of applications(4) 
In imaging and biosensing applications
In bioactive cargo delivery
In cancer therapy
Covering cellular territory
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Imaging and Biosensing(4)
 Deliver quantum dots across BBB
 Deliver antiobiotics
 Visualize viral infections
 Deliver  intracellular biosensors
Quantum dots conjugated to CPPs are able to cross 
the highly impermeable blood-brain barrier(4)
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Radioimmunoconjugates can
access intracellular molecules upon conjugation to CPPs(4)
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Molecular beacons attached to CPPs can be 
harnessed to visualize viral infection in real 
time(4)
Carbonic anhydrase, has been conjugated to CPPs 
to yield a highly sensitive biosensor for measuring 
intracellular zinc levels(4)
21
22
23
Structure of molecular beacons in their native conformations (top) or hybridized with a DNA 
strand (bottom) 24
Delivery of QDs congugated with CPPs
Via endocytic pathways
combined with HR9
_ Stably but noncovalently conjugated
_ Entered in 4min
_ Penetrates cell membrane directly*
_ Stay in cytosol without any organelle
capture
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Dimethyl sulphoxide, ethanol and oleic acid
enhanced intracellular delivery of HR9-QDs 
(by promoting the direct membrane translocation)
HR9         no cytotoxicity
an efficient carrier to deliver drugs 
without interfering with their therapeutic activity
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Harnessing CPPs to more efficiently deliver 
antigens intracellularly could dramatically 
improve vaccine efficacy(4)
Vaccine delivery
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 Increase appoptosis on drug resistant cancer cell lines
 Increase the efficacy of cancer drugs used in
chemotherapy
 Combining CPPs with tumour homing domains
Selectively delivery to cancer cells
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 Increased retention in tumours
(by decreasing efflux out of the cell)
 Overcome drug resistance(by increased 
intracellular drug concentrations in
tumour cells)(4)
Conjugation of CPPs to drug
molecules allows For:
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Covering cellular territory
They often remain sequestered in
endosomes
CPPs being modified to improve
endosomal scape
To deliver cargo to subcellular organelles
To deliver specially anionic cargo
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Improving endosomal escape to achieve increased 
biological activity(4) 32
 why this is advantegous?
A. Simplifies conjugation protocols
B. Delivering different cargo simply(by mixing the 
two Compounds)
C. Dicrease the likelihood of interfering with 
the bioactively of the payload
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One such CPP is:
Rath peptide,derived from the avian infectious virus
It adopts a dominant β-structure, unusual for CPPs
Delivery of both proteins and nucleic acids
The delivery is rapid (30 min for an 
oligonucleotide and 1 h for an antibody)
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Temperature independent,
A nonendocytic mechanism of uptake
It avoids endosomal entrapment
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CADY is another this kind of peptide
Example:
MPPS  (mitochondria-penetrating peptides)
 By making a balance between cationic character and 
hydrophobicity
 gain mitochondrial access efficiently
 Study the cellular responses to ROS
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A antimicrobial peptide
 Found in human salvia
 It’s target fungal and protozoan mitochondria
Accumulate within the mitochondria and inhibit 
F1F0-ATPase
Causes collaps of the parasite(4)
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